Pharmaxis Ltd, a clinical stage drug development company, engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. It operates through Mannitol Respiratory Business and New Drug Development segments. The company provides Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, a lung function test for the treatment of asthma. It's product pipeline comprises oral pan-Lysyl Oxidase Inhibitors (LOX) targeting myelofibrosis and other cancers; topical pan-LOX inhibitors targeting skin scarring after events such as accidents, surgery, and burns; selective Lysyl Oxidase Like Inhibitors (LOXL2) targeting chronic fibrotic diseases including kidney, pulmonary, liver, and cardiac fibrosis; and semicarbazide-sensitive amine oxidase for neuro inflammatory diseases. The company also offers Orbital, a dry powder inhaler to deliver high drug doses to lungs. Pharmaxis Ltd was incorporated in 1998 and is headquartered in Frenchs Forest, Australia.
| Market Capitalization | $25.9946 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | 0 |
| Book Value | 0.013 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.02 |
| EBITDA | -10,054 |
| Profit Margin | -0.592 |
| Operating Margin TTM | -0.6183 |
| Return on Assets TTM | -0.3014 |
| Return on Equity TTM | -1.1158 |
| Revenue TTM | 19,189 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2002-06-30 | 10 | |||
| 2003-06-30 | 41.441 | 41.441 | 3,026.972 | |
| 2004-06-30 | 8,718.475 | |||
| 2005-06-30 | 0.5 | 0.5 | 13,732.628 | |
| 2006-06-30 | 8 | 2 | 6 | 24,107 |
| 2007-06-30 | 205 | 49 | 156 | 32,685 |
| 2008-06-30 | 527 | 129 | 398 | 30,808 |
| 2009-06-30 | 595 | 153 | 442 | 42,575 |
| 2010-06-30 | 1,170 | 307 | 863 | 53,533 |
| 2011-06-30 | 1,202 | 342 | 860 | 53,992 |
| 2012-06-30 | 1,466 | 522 | 944 | 50,586 |
| 2013-06-30 | 3,237 | 1,141 | 2,096 | 54,186 |
| 2014-06-30 | 5,036 | 1,858 | 3,178 | 58,411 |
| 2015-06-30 | 57,741 | 1,737 | 57,741 | 43,104 |
| 2016-06-30 | 14,335 | 1,928 | 14,335 | 36,918 |
| 2017-06-30 | 13,286 | 1,326 | 13,286 | 36,505 |
| 2018-06-30 | 7,282 | 1,774 | 7,282 | 33,629 |
| 2019-06-30 | 5,676 | 1,374 | 5,676 | 31,560 |
| 2020-06-30 | 7,027 | 1,456 | 7,027 | 28,494 |
| 2021-06-30 | 6,680 | 1,168 | 6,680 | 27,322 |
| 2022-06-30 | 7,426 | 2,729 | 7,426 | 30,194 |
| 2023-06-30 | 5,765 | 2,706 | 3,059 | 31,053 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2002-06-30 | 751 | 2,144 | 190 | 1,400 | ||
| 2003-06-30 | 26,683.923 | 29,794.556 | 604.495 | 32,104.529 | ||
| 2004-06-30 | 25,217.023 | 28,261.02 | 1,480.789 | 35,695.368 | ||
| 2005-06-30 | 934.778 | 37,937.437 | 2,368.711 | 32,454.645 | 54,716.22 | |
| 2006-06-30 | 97,840 | 104,267 | 5,379 | 134,745 | ||
| 2007-06-30 | 76,182 | 82,648 | 6,089 | 135,108 | ||
| 2008-06-30 | 111,842 | 125,049 | 5,928 | 194,680 | ||
| 2009-06-30 | 124,993 | 163,997 | 26,306 | 316 | 13,559 | 245,958 |
| 2010-06-30 | 85,787 | 140,767 | 25,751 | 371 | 13,158 | 267,050 |
| 2011-06-30 | 44,343 | 94,572 | 23,742 | 443 | 12,716 | 267,610 |
| 2012-06-30 | 81,475 | 131,700 | 21,897 | 515 | 12,145 | 344,388 |
| 2013-06-30 | 63,943 | 112,280 | 44,385 | 594 | 11,560 | 344,623 |
| 2014-06-30 | 34,182 | 66,747 | 48,680 | 679 | 10,893 | 344,623 |
| 2015-06-30 | 54,138 | 82,558 | 46,237 | 772 | 10,121 | 344,623 |
| 2016-06-30 | 39,209 | 65,653 | 44,727 | 864 | 9,258 | 344,623 |
| 2017-06-30 | 21,504 | 45,434 | 41,913 | 981 | 8,270 | 344,623 |
| 2018-06-30 | 31,073 | 50,097 | 38,979 | 1,098 | 7,171 | 344,623 |
| 2019-06-30 | 31,124 | 52,668 | 37,854 | 1,203 | 7,171 | 367,301 |
| 2020-06-30 | 14,764 | 35,416 | 33,985 | 1,832 | 367,301 | |
| 2021-06-30 | 18,712 | 33,590 | 30,745 | 2,032 | 371,366 | |
| 2022-06-30 | 8,937 | 25,186 | 14,382 | 2,031 | 380,440 | |
| 2023-06-30 | 9,230 | 24,026 | 14,467 | 2,043 | 389,699 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2002-06-30 | ||||||
| 2003-06-30 | 7,383.923 | |||||
| 2004-06-30 | -4,652.15 | 17,833.1 | 7,383.923 | 25,217.023 | ||
| 2005-06-30 | -10,232.357 | -9,274.214 | 8,172.4 | 25,217.023 | 33,389.423 | |
| 2006-06-30 | -17,733 | -13,775 | 64,450 | 33,390 | 97,840 | |
| 2007-06-30 | -24,179 | -20,697 | -21,658 | 97,840 | 76,182 | |
| 2008-06-30 | -20,440 | -18,850 | 35,660 | 76,182 | 111,842 | |
| 2009-06-30 | -35,171 | -26,469 | 13,151 | 111,842 | 124,993 | |
| 2010-06-30 | -46,345 | -39,683 | -39,206 | 124,993 | 85,787 | |
| 2011-06-30 | -45,758 | -37,366 | -41,444 | 85,787 | 44,343 | |
| 2012-06-30 | -38,644 | -38,142 | 37,132 | 44,343 | 81,475 | |
| 2013-06-30 | -43,537 | -35,383 | -17,532 | 81,475 | 63,943 | |
| 2014-06-30 | -51,818 | -28,132 | -29,761 | 63,943 | 34,182 | |
| 2015-06-30 | 18,466 | 21,780 | 19,956 | 34,182 | 54,138 | |
| 2016-06-30 | -16,463 | -11,989 | -14,929 | 54,138 | 39,209 | 0 |
| 2017-06-30 | -18,346 | -15,262 | -17,705 | 39,209 | 21,504 | 0 |
| 2018-06-30 | 6,428 | 12,206 | 9,569 | 21,504 | 31,073 | |
| 2019-06-30 | -20,296 | -19,798 | 51 | 31,073 | 31,124 | |
| 2020-06-30 | -6,419 | -13,284 | -16,360 | 31,124 | 14,764 | |
| 2021-06-30 | -3,339 | 3,072 | 3,948 | 14,764 | 18,712 | |
| 2022-06-30 | 11,520 | 14,758 | -9,775 | 18,712 | 8,937 | |
| 2023-06-30 | -11,360 | -7,277 | 293 | 8,937 | 9,230 |